Overview Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Status: Recruiting Trial end date: 2027-10-30 Target enrollment: Participant gender: Summary Neoadjuvant chemotherapy plus toripalimab in patients with locoregionally advanced nasopharyngeal carcinoma Phase: Phase 2 Details Lead Sponsor: Zhejiang Cancer Hospital